Although AD‐PGS was not significantly associated with clinical AD dementia, the presence of APOE‐ε4 in participants diagnosed with clinical AD dementia was associated with an accelerated timing of clinical AD dementia diagnosis by approximately 33.9 months. Here, APOE is linked to Alzheimer disease.